Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of ACR-368 in patients with ovarian (OvCa) or endometrial carcinoma (EnCa) and prospective validation of OncoSignature patient selection (NCT05548296)
    Meeting Abstract

    Lee, J. M.; MacLaughlan, S.; Matei, D.; Song, M.; Brubaker, L.; Rimmel, B.; Eskander, R. N.; Kyi, C.; Williams, H.; Duska, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase I safety and efficacy of brenetafusp, a PRAME x CD3 ImmTAC T cell engager, in platinum resistant ovarian cancer (PROC)
    Meeting Abstract

    Friedman, C.; De Burgh Williams, A.; Lopez, J. S.; Ouali, K.; Middleton, M. R.; Thistlethwaite, F.; Hamid, O.; Izar, B.; Moreno Garcia, V.; Johnson, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Characterization of tumor response with lenvatinib plus pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 study
    Meeting Abstract

    Danska-Bidzinska, A.; Makker, V.; Salutari, V.; Ayhan, A.; Romero, I.; Levy, T.; McCormack, M.; Baurain, J. F.; Mach, P.; Cadoo, K. A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • First clinical results from a phase I trial of PRT3789: A first-in-class intravenous SMARCA2 degrader, in patients with advanced solid tumors with a SMARCA4 mutation
    Meeting Abstract

    Guo, R.; Dowlati, A.; Dagogo-Jack, I.; Vibert, J.; Spira, A. I.; Moreno Garcia, V.; Punekar, S.; Calvo, E.; Sonpavde, G. P.; Awad, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Final overall survival (OS) in patients (pts) with newly diagnosed advanced ovarian cancer (aOC) treated with niraparib (nir) first-line (1L) maintenance: Results from PRIMA/ENGOT-OV26/GOG-3012
    Meeting Abstract

    González-Martín, A.; Pothuri, B.; Ginesta, M. P. B.; Graybill, W. S.; Vergote, I. B.; McCormick, C.; Mirza, M. R.; Moore, R. G.; Lorusso, D.; O'Cearbhaill, R. E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • An open-label, multicenter, phase II study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) part 2
    Meeting Abstract

    Lee, J. Y.; Makker, V.; Oaknin, A.; Oh, D. Y.; Anoka, C.; Jung, L.; Simoes, J.; Puvvada, S. D.; Meric-Bernstam, F.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Assessing minimally invasive simple hysterectomy in low risk cervical cancer: Set up for the LASH trial
    Review

    Bizzarri, N.; Abu-Rustum, N. R.; Plante, M.; Ramirez, P. T.; Chiva, L.; Falconer, H.; Cibula, D.; Querleu, D.; Fanfani, F.; Fagotti, A.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib
    Journal Article

    Barnicle, A.; Ray-Coquard, I.; Rouleau, E.; Cadoo, K.; Simpkins, F.; Aghajanian, C.; Leary, A.; Poveda, A.; Lheureux, S.; Pujade-Lauraine, E.; more...
    Genome Medicine (2024)

    Fulltext@MSK | Save
  • It doesn't have to be this way: How to assess and treat cancer related financial toxicity
    Meeting Abstract

    Caramore, A.; Sharma, B.; Thom, B.; Aviki, E.; Vega, L.
    Oncology Nursing Forum (2024)

    Fulltext@MSK | Save